The cellular neurobiology of depression

Nature Medicine

Volumn 7, Issue 5, 2001, Pages 541-547

  Manji, Husseini K ^a   Drevets, Wayne C ^a   Charney, Dennis S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID ANTAGONIST; GLUTAMATE RECEPTOR ANTAGONIST; LITHIUM;

CELL SURVIVAL; DEPRESSION; DISEASE ASSOCIATION; HUMAN; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANTIDEPRESSIVE AGENTS; CELL SURVIVAL; DEPRESSIVE DISORDER; GLUCOCORTICOIDS; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION;

EID: 0035034203     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/87865     Document Type: Review

References (72)

1. Musselman, D.L., Evans, D.L. & Nemeroff, C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55, 580-592 (1998).
2. Schulz, R. et al. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch. Intern. Med. 160, 1761-1768 (2000).
3. Michelson, D. et al. Bone mineral density in women with depression. N. Engl. J. Med. 335, 1176-1181 (1996).
4. Ciechanowski, P.S., Katon, W.J. & Russo, J.E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med. 160, 3278-3285 (2000).
5. Murray, C.J. & Lopez, A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436-1442 (1997).
6. Schatzberg, A.F. & Schildkraut, J.J. Recent studies on norepinephrine systems in mood disorders. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 911-920 (Raven, New York, 1995).
7. Maes, M. & Meltzer, H.Y. The serotonergic hypothesis of depression. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 921-932 (Raven, New York, 1995).
8. Willner, P. Dopaminergic mechanisms in depression and mania. in Psychopharmacology: The fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 921-932 (Raven, New York, 1995).
9. Janowsky, D.S. & Overstreet, D.H. The role of acetylcholine mechanisms in mood disorders. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 945-956 (Raven, New York, 1995).
10. Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348-364 (Oxford Press, New York, 1999).
11. Drevets, W.C. Neuroimaging studies of mood disorders: Implications for a neural model of major depression. Biol. Psychiatry 48, 813-829 (2000).
12. Graybiel, A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254 (1990).
13. Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394-418 (Oxford Press, New York, 1999).
14. Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501 (2000).
15. Owens, M.J. & Nemeroff, C.B. Corticotropin-releasing factor antagonists in affective disorders. Expert. Opin. Investig. Drugs 8, 1849-1858 (1999).
16. Charney, D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59, 11-14 (1998).
17. Manji, H.K. & Lenox, R.H. Signaling: Cellular insights into the pathophysiology of bipolar disorder. Biol. Psych. 48, 518-530 (2000).
18. Manji, H.K., Moore, G.J., Rajkowska, G. & Chen, G. Neuroplasticity and cellular resilience in mood disorders. Millennium article. Mol. Psychiatry 5, 578-593 (2000).
19. Bourne, H.R. & Nicoll, R. Molecular machines integrate coincident synaptic signals. Cell 72, 65-75 (1993).
20. Bhalla, U.S. & Iyengar, R. Emergent properties of networks of biological signaling pathways. Science 283, 381-387 (1999).
21. LeDoux, J.E. Emotion. in Handbook of Physiology - The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373-417 (Williams & Wilkins, Baltimore, 1987).
22. Rajkowska, G. et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45, 1085-1098 (1999).
23. Rajkowska, G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48, 766-777 (2000).
24. Öngür, D., Drevets, W.C. & Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Nat. Acad. Sci. USA 95, 13290-13295 (1998).
25. Coyle, J.T. & Schwarcz, R. Mind glue: implications of glial cell biology for psychiatry. Arch. Gen. Psychiatry 57, 90-93 (2000).
26. Ullian, E.K., Sapperstein, S.K., Christopherson, K.S. & Barres, B.A. Control of synapse number by glia. Science 291, 657-660 (2001).
27. Drevets, W. Neuroimaging and neuropathological studies of depression: Implications for the cognitive emotional manifestations of mood disorders. Curr. Op. Neurobiol. 11, 240-249 (2001).
28. Folstein, S.E., Peyser, C.E., Starkstein, S.E. & Folstein, M.F. Subcortical triad of Huntington's Disease; a model for a neuropathology of depression, dementia, and dyskinesia. in Psychopathology and the Brain. (ed. Carroll, B.J.) 65-75 (Raven, New York, 1991).
29. Starkstein, S.E. & Robinson, R.G. Affective disorders and cerebral vascular disease. Brit. J. Psychiatry 154, 170-182 (1989).
30. Starkstein, S.E. & Robinson, R.G. Mood disorders in neurodegenerative diseases. Semin. Clin. Neuropsychiatry 4, 272-281 (1996).
31. Kessler, R.C. The effects of stressful life events on depression. Annu. Rev. Psychol. 148, 191-214 (1997).
32. McEwen, B.S. Stress and hippocampal plasticity. Ann. Rev. Neurosci. 22, 105-122 (1999).
33. Sapolsky, R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57, 925-935 (2000).
34. Brown, E.S., Rush, A.J. & McEwen, B.S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 21, 474-484 (1999).
35. Sonino, N. & Fava, G.A. Psychosomatic aspects of Cushing's disease. Psychother. Psychosom. 67, 140-146 (1998).
36. Starkman, M.N. et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry 46, 1595-1602 (1999).
37. Steffens, D.C., Tupler, L.A. & Krishnan, R. Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. Psychiatry Res. 83, 95-103 (1998).
38. Black, I.B. Trophic regulation of synaptic plasticity. J. Neurobiol. 41, 108-118 (1999).
39. Riccio, A., Ahn, S., Davenport, C.M., Blendy, J.A. & Ginty, D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358-2361 (1999).
40. Bonni, A., Brunet, A., West, A.E., Datta, S.R. & Takasu, M.A. Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms. Science 286, 1358-1362 (1999).
41. Finkbeiner, S. CREB couples neurotrophin signals to survival messages. Neuron 25, 11-14 (2000).
42. Adams, J.M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-13226 (1998).
43. Chen, D.F., Schneider, G.E., Martinou, J.C. & Tonegawa, S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385, 434-439 (1997).
44. Eriksson, P.S. et al. Neurogenesis in the adult human hippocampus. Nature Med. 4, 1313-1317 (1998).
45. Duman, R.S., Malberg, J., Nakagawa, S. & D'Sa, C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48, 732-739 (2000).
46. Gould, E., Tanapat, P., Rydel, T. & Hastings, N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry 48, 715-720 (2000).
47. Jacobs, B.L., Praag, H. & Gage, F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry. 5, 262-269 (2000).
48. Gould, E., Reeves, A.J., Graziano, M.S. & Gross, C.G. Neurogenesis in the neo-cortex of adult primates. Science 286, 548-552 (1999).
49. Graham, Y.P., Heim, C., Goodman, S.H., Miller, A.H. & Nemeroff, C.B. The effects of neonatal stress on brain development: Implications for psychopathology. Dev. Psychopathol. 11, 545-565 (1999).
50. Heim, C. & Nemeroff, C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry 46, 1509-1522 (1999).
51. Francis, D., Diorio, J., Liu, D. & Meaney, M.J. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286, 1155-1158 (1999).
52. Duman, R.S., Heninger, G.R. & Nestler, E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54, 597-606 (1997).
53. Malberg, J.E., Eisch, A.J., Nestler, E.J. & Duman, R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104-9410 (2000).
54. Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129-177 (American Psychiatric Press, Washington, DC, 2000).
55. Petrie, R.X., Reid, I.C. & Stewart, C.A. The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review. Pharmacol. Ther. 87, 11-25 (2000).
56. Chen, G. et al. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72, 879-882 (1999).
57. Chen, R.W. & Chuang. D.M. Long term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression. J. Biol. Chem. 274, 6039-6042 (1999).
58. Klein, P.S. & Melton, D,A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459 (1996).
59. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N. & Manji, H.K. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75, 1729-1734 (2000).
60. Tsai, G. & Coyle, J.T. N-acetylaspartate in neuropsychiatric Disorders. Prog. Neuroiology 46, 531-540 (1995).
61. Bates, T.E. et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7, 1397-1400 (1996).
62. Moore, G.J. et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol. Psychiatry 48, 1-8 (2000).
63. Moore, G.J., Bebchuk, J.M., Wilds, I.B., Chen, G. & Manji, H.K. Lithium-induced increase in human brain gray matter. Lancet 356, 1241-1242 (2000).
64. Calabrese, J.R. et al. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am. J. Psychiatry 156, 1019-1023 (1999).
65. Berman, R.M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351-354 (2000).
66. Wolkowitz, O.M. & Reus, V.I. Treatment of depression with antiglucocorticoid drugs. Psychosom. Med. 61, 698-711 (1999).
67. Nestler, E.J. Antidepressant treatments in the 21st century. Biol. Psychiatry 44, 526-533 (1998).
68. Guo, Z., Zhou, D. & Schultz, P.G. Designing small-molecule switches for protein-protein interactions. Science 288, 2042-2045 (2000).
69. Mesulam, M.M. Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles. Neuron 24, 521-529 (1999).
70. Sweatt, J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 1-10 (2001).
71. Sanacora, G. et al. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56, 1043-1047 (1999).
72. Lambert, G., Johansson, M., Agren, H. & Friberg, P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch. Gen. Psychiatry 57, 787-793 (2000).